新闻动态

发表文献

自主转化医学研究推动创新药物研发

/
/
Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling

Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling

2021-05-07 20:27
应世

版权所有 © 2019  应世汇康(北京)生物科技有限公司  京ICP备19001572号-1  网站建设:中企动力  北京